Vitality Biopharma to Present at LD Micro and BIO Conferences

LOS ANGELES, CA--(Marketwired - Jun 1, 2016) - Vitality Biopharma, Inc. (OTCQB: STVF), a company dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that Company CEO Mr. Robert Brooke will be presenting and meeting with investors at the upcoming 2016 LD Micro Invitational and BIO International Conference in June.

6^th Annual LD Micro Invitational Conference
Vitality Biopharma to present on Tuesday, June 7th at 7:30AM PST. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles and will feature 195 companies in the small / micro-cap space. 

BIO International Convention
Vitality Biopharma to present on Thursday, June 9th at 11:00AM PST in Theatre 2. The convention will be held at the Moscone Center in San Francisco, June 6-9 and provides an opportunity to network with 2,500 CEOs and 15,000+ attendees from 69 countries.

Learn More about Vitality Biopharma
Corporate Website: www.vitality.bio
Watch the video: https://youtu.be/nerz4wqeP3Y
Note: Stevia First Corp. (OTCQB: STVF) recently received shareholder approval for a name change to Vitality Biopharma, Inc. Submission for a new trading symbol is underway.

About Vitality Biopharma (OTCQB: STVF)
Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: www.vitality.bio. Follow us on Facebook, Twitter and LinkedIn. 

About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event). For those interested in attending, please visit www.ldmicro.com for more information.

About BIO International Convention
The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy. For more information visit: www.convention.bio.org.